Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Total Non-Current Liabilities (2009 - 2026)

Evotec SE's (EVO) quarterly Total Non-Current Liabilities came in at $30.5 million in Q2 2026, up 41.95% year-over-year from $21.5 million in Q2 2025, and down 59.42% quarter-over-quarter from $75.1 million in Q1 2026.

Analysis

Evotec SE (EVO) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $30.5 million for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities rose 41.95% year-over-year to $30.5 million; the TTM figure through Jun 2026 stood at $30.5 million (up 41.95% YoY), while the FY2025 annual figure was $20.4 million, down 3.88% from the prior year.
  • Total Non-Current Liabilities came in at $30.5 million for Q2 2026 at Evotec SE, down from $75.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $75.1 million in Q1 2026 to a low of $404414.5 in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $23.6 million, with a median of $20.9 million recorded in 2024.
  • Year-over-year, Total Non-Current Liabilities tumbled 32.85% in 2022 and jumped 4380.75% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $16.8 million in 2022, then gained by 3.12% to $17.3 million in 2023, then rose by 21.09% to $20.9 million in 2024, then climbed by 0.31% to $21.0 million in 2025, then soared by 45.22% to $30.5 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $30.5 million in Q2 2026, $75.1 million in Q1 2026, and $21.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 22.94 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 1.56 Bn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 4.24 Bn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 6.94 Bn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 2.15 Bn
6 Evotec SE 642.83 Mn 216.96 Mn - 30.49 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 553.39 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 22.91 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.49 Mn
Mar 31, 2026 75.13 Mn
Dec 31, 2025 20.99 Mn
Sep 30, 2025 21.33 Mn
Jun 30, 2025 21.48 Mn
Mar 31, 2025 20.78 Mn
Dec 31, 2024 20.93 Mn
Sep 30, 2024 29.73 Mn
Dec 31, 2023 17.28 Mn
Jun 30, 2023 18.12 Mn
Dec 31, 2022 16.76 Mn
Sep 30, 2022 17.89 Mn
Jun 30, 2022 404,414.48
Mar 31, 2022 19.37 Mn
Dec 31, 2021 20.62 Mn
Sep 30, 2021 26.64 Mn
Dec 31, 2020 24.72 Mn
Sep 30, 2010 9.09 Mn
Jun 30, 2010 1.12 Mn
Mar 31, 2010 1.14 Mn